• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » J&J ditches DePuy trauma business ahead of Synthes merger

J&J ditches DePuy trauma business ahead of Synthes merger

April 3, 2012 By MassDevice staff

Updated April 3, 2012, at 1:00 p.m. with comments from Biomet.

M&A illustration

Biomet Inc. signed a binding offer to pay $280 million in cash for Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopedics‘ global trauma business.

Warsaw, Ind.-based Biomet hopes to expand its sports, extremities and trauma division with the acquisition, which will see DePuy’s trauma employees folded into the Biomet team.

"The DePuy Trauma team has done a great job of building a successful business," Biomet president & CEO Jeffrey Binder said in prepared remarks. "We look forward to welcoming them as Biomet team members and working alongside them to fulfill our commitment to providing customers with outstanding products and service, as well as continued innovation."

The deal comes amid J&J’s attempted $21.3 billion buyout of Synthes, a move that raised eyebrows among regulators at the European Commission, which regulates competition and antitrust efforts for the European Union.

J&J submitted concessions the European authorities in February, hoping to grease the wheels. EuroZone regulators delayed the deadline for a decision on the proposed merger until April 26.

A Biomet spokesman declined to disclose additional terms of the deal, but told MassDevice.com that it is the company’s "intention to invest in and grow our combined trauma business well ahead of the market."

Biomet chose not to speculate on when the deal may close, but Johnson & Johnson officials said in a statement that the sale will likely close in the 2nd quarter, Reuters reported.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Biomet, depuysynthes, Johnson and Johnson

More recent news

  • Penumbra completes enrollment in pulmonary embolism trial
  • Zoll opens new facility in Rhode Island
  • FDA expands clearance for Inquis Medical’s Aventus thrombectomy system
  • SS Innovations completes first robotic cardiac surgery in the Americas
  • GI Windows wins FDA nod for magnet tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy